Microchimica Acta, Journal Year: 2025, Volume and Issue: 192(5)
Published: May 1, 2025
Language: Английский
Microchimica Acta, Journal Year: 2025, Volume and Issue: 192(5)
Published: May 1, 2025
Language: Английский
Current Opinion in Pediatrics, Journal Year: 2020, Volume and Issue: 32(5), P. 698 - 706
Published: Sept. 3, 2020
Purpose of review This provides a model for understanding polycystic ovary syndrome (PCOS) pathophysiology and updates the evidence on which it is based. Then, highlights complimentary molecular genetic epigenetic advances in PCOS cause. Recent findings Important studies into cause built 2014 discovery novel regulatory protein variant that underlies typical steroidogenic abnormalities: DENND1A.V2 (differentially expressed normal neoplastic development, isoform 1A, 2). Over 30 DENND1A gene variants have been found, vast majority upstream coding sequence potentially regulatory. These are individually uncommon but collectively plausibly 50% PCOS. Anti-Müllerian hormone (AMH)/AMH receptor with decreased function possibly 6.7% DENNND1A was recently reported to belong signaling network upregulates luteinizing expression insulin mitogenic signaling. Prenatal androgen administration has proven be potent regulator causes transgenerational epigenomic changes mouse similarities those human daughters. Summary In addition finding how contribute pathogenesis, better mechanisms action diverse tissues can expected expand our pathogenesis.
Language: Английский
Citations
52Frontiers in Endocrinology, Journal Year: 2020, Volume and Issue: 11
Published: April 30, 2020
Polycystic ovary syndrome is characterized by reproductive and metabolic disturbances throughout the female lifespan. Therefore, this study aimed to determine whether genome-wide association studies (GWAS)-identified risk variants for PCOS could confer of (MS) or insulin resistance (IR). Fifteen independent SNPs mapping 11 GWAS loci genotyped in a total 2082 Han Chinese women previous phenotype-genotype correlations were assessed. The CC group rs12478601 THADA was associated with decreased rate MS after adjustment age (23.2% vs 27%, P = 0.042, OR 0.81). Using dominant model, GG+AG rs2059807 INSR increased (26.8% 22.5%, 0.023, 1.27). GG + GT rs4784165 TOX3 found be an IR BMI(53.3% 48.5%, 0.027, 1.27).The rs2479106 DENND1A (48.3% 53.6%, adjusted 0.039, 0.80). After exclusion cases family history diabetes, hypertension, dyslipidemia, between genes still significant (P < 0.05). Three (rs13429458 THADA, rs10818854 DENND1A, INSR) significantly IR; however, their not BMI. This genotype-phenotype thus provides clues that INSR, TOX3, play role possibly through disorder-related pathway.
Language: Английский
Citations
51Clinical Endocrinology, Journal Year: 2023, Volume and Issue: 99(1), P. 79 - 91
Published: March 20, 2023
Abstract Objective As part of the update International Evidence‐Based Guidelines for Assessment and Management polycystic ovary syndrome (PCOS), a systematic review was performed to inform evidence‐based recommendations. Design Systematic review. Only randomised controlled trial were included. Patients Women with PCOS; use combined oral contraceptive pills (COCP) compared no medical treatment. Measurements Outcomes designed in collaboration clinical experts, researchers, consumers. Critical outcomes included hirsutism, irregular cycles, quality life, body mass index (BMI), weight. Results 1660 publications identified, but only four studies No could be meta‐analysis. COCP treatment improved cycle regularity (100% vs. 0%, low certainty evidence). showed difference improvement hirsutism or BMI placebo lifestyle; lower weight after (mean [MD] −8.0 (95% confidence interval, CI −11.67); −4.33 kg); life (MD 1.2 [95% 0.96]; 1.44), these results all very evidence. Conclusion show that benefit regulation, other benefits potential adverse effects identified The is frontline PCOS, this still based on established efficacy broader general population. Our research PCOS seriously lacking should prioritised capture core reproductive, metabolic psychological important PCOS.
Language: Английский
Citations
19BMC Genomics, Journal Year: 2024, Volume and Issue: 25(1)
Published: Feb. 26, 2024
Polycystic ovary syndrome (PCOS) is a complex multifactorial disorder with substantial genetic component. However, the clinical manifestations of PCOS are heterogeneous notable differences between lean and obese women, implying different pathophysiology manifesting in differential body mass index (BMI). We performed meta-analysis genome-wide association study (GWAS) data from six well-characterised cohorts, using case-control design stratified by BMI, aiming to identify variants associated overweight/obese subtypes.
Language: Английский
Citations
8Life Sciences, Journal Year: 2022, Volume and Issue: 300, P. 120560 - 120560
Published: April 19, 2022
Language: Английский
Citations
24Medical Sciences, Journal Year: 2019, Volume and Issue: 7(12), P. 107 - 107
Published: Nov. 27, 2019
Indian rhesus macaque nonhuman primate models for polycystic ovary syndrome (PCOS) implicate both female hyperandrogenism and developmental molecular origins as core components of PCOS etiopathogenesis. Establishing exploiting translational impact into the clinic, however, has required multi-year, integrated basic-clinical science collaborations. Paradigm shifting insight accrued from such concerted investment, leading to novel mechanistic understanding PCOS, including hyperandrogenic fetal peripubertal origins, epigenetic programming, altered neural function, defective oocytes embryos, adipogenic constraint enhancing progression insulin resistance, pancreatic decompensation type 2 diabetes, together with placental compromise, all contributing transgenerational transmission traits likely manifest in adult phenotypes. Our recent demonstration PCOS-related naturally (High T) macaques additionally creates opportunities employ whole genome sequencing enable exploration gene variants within human candidate genes models. This review will therefore consider model contributions various aspects pathophysiology, well benefits using compellingly close homologies genome, phenotype, development aging.
Language: Английский
Citations
39Cell Genomics, Journal Year: 2021, Volume and Issue: 1(1), P. 100005 - 100005
Published: Oct. 1, 2021
Genome sequencing has recently become a viable genotyping technology for use in genome-wide association studies (GWASs), offering the potential to analyze broader range of variation, including rare variants. To survey current standards, we assessed content and quality reporting statistical methods, analyses, results, datasets 167 exome- or genome-wide-sequencing-based GWAS publications published from 2014 2020; 81% included tests aggregate across multiple variants, with test models frequently used. We observed lack standardized terms incomplete datasets, particularly variants analyzed tests. also find lower frequency sharing summary statistics compared array-based GWASs. Reporting standards increased data are required ensure sequencing-based study findable, interoperable, accessible, reusable (FAIR). support that, recommend adopting standard terminology (seqGWAS). Further, that single-variant analyses be reported following same conventions as GWASs shared Catalog. provide initial recommended metadata statistics.
Language: Английский
Citations
29Endocrine Reviews, Journal Year: 2024, Volume and Issue: 45(4), P. 553 - 592
Published: March 8, 2024
Abstract From 1965 to 2015, immense strides were made into understanding the mechanisms underlying common androgen excess disorders, premature adrenarche and polycystic ovary syndrome (PCOS). The author reviews critical discoveries of this era from his perspective investigating these commencing with early unique pattern plasma androgens in elevation an index free testosterone concentration most hirsute women. molecular genetic basis, though not developmental biologic for is now known 11-oxytestosterones shown be major bioactive adrenal androgens. evolution lines research pathogenesis PCOS historically traced: milestones are cited areas neuroendocrinology, insulin resistance, hyperinsulinism, type 2 diabetes mellitus, folliculogenesis, secretion, obesity, phenotyping, prenatal androgenization, epigenetics, complex genetics. Large-scale genome-wide association studies led 2014 discovery unsuspected steroidogenic regulator DENND1A (differentially expressed normal neoplastic development). splice variant DENND1A.V2 constitutively overexpressed theca cells long-term culture accounts their PCOS-like phenotype. genetics complex, however: intronic copy number related phenotype severity, recent data indicate that rare variants a regulatory network other genes PCOS. Obesity exacerbates manifestations via resistance proinflammatory cytokine excess; adipose tissue also forms testosterone. Polycystic ovaries 40 percent apparently women lie on functional spectrum. Much remains learned.
Language: Английский
Citations
4Current Opinion in Endocrine and Metabolic Research, Journal Year: 2020, Volume and Issue: 12, P. 26 - 32
Published: April 4, 2020
Language: Английский
Citations
28Frontiers in Immunology, Journal Year: 2021, Volume and Issue: 12
Published: Feb. 26, 2021
Polycystic ovary syndrome (PCOS) and Hashimoto’s thyroiditis (HT) are endocrine disorders that commonly occur among young women. A higher prevalence of HT in women with PCOS, relative to healthy individuals, is observed consistently. Combined occurrence both diseases associated a risk severe metabolic reproductive complications. Genetic factors strongly impact the pathogenesis PCOS several susceptibility loci have been identified. Furthermore, some candidate gene polymorphisms thought be functionally relevant; however, few genetic variants proposed causally incidence together.
Language: Английский
Citations
25